Navigation Links
Aethlon Medical Receives FDA Approval to Export its Hemopurifier® to India
Date:3/8/2011

ed around approximately 2800 porous hollow fibers that run the interior length of our device. The resulting design provides us the novel ability to separate both exosome and viral targets away from blood cells so they can then be selectively and permanently removed from the circulatory system. In application, blood circulation is established into the Hemopurifier® via a catheter or other blood access device. Once blood flow has been established, treatment benefit is immediate as the entire circulatory system can pass through the Hemopurifier® in as little as 15 minutes.

Our wholly owned subsidiary, Exosome Sciences, Inc. (ESI) is focused on the development of exosome-targeted products and services that improve cancer diagnosis, provide post-treatment cancer surveillance, and aid in the discovery of biomarkers that allow doctors to optimize patient therapy. Additional information regarding Aethlon Medical and Exosome Sciences can be accessed online at www.aethlonmedical.com.

Certain of the statements herein may be forward-looking and involve risks and uncertainties. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc. to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements.  Such potential risks and uncertainties include, without limitation, the company's ability to commercialize its Hemopurifier® in India, capability of the Hemopurifier® to reduce viral loads and other disease conditions or to identify or treat disease conditions such as cancer or Hepatitis-C, including the ability to capture exoso
'/>"/>

SOURCE Aethlon Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Aethlon Medical Releases Shareholder Letter
2. Aethlon Medical to Host Investor Event on January 20, 2011
3. Aethlon Medical Announces Presentation at U.S. Department of Health and Human Services BARDA Industry Day
4. A Platform Technology to Address Bioterrorism Released by Aethlon Medical, Inc.
5. Aethlon Medical to Present at the Singular Research Fifth Annual Best of the Uncovereds Conference
6. Aethlon Medical Names Rod Kenley President
7. Aethlon Medical Announces Appointment of Rod Kenley to Its Board of Directors
8. Aethlon Medical Engages Fabiani & Company to Advance U.S. Government Partnerships
9. Aethlon Medical Reestablishes Biodefense Programs
10. Aethlon Medical to Present at Rodman & Renshaw Annual Global Investment Conference
11. Aethlon Medical Announces Approval of Hepatitis C Virus (HCV) Treatment Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... 2014 Research and Markets ( ... "Investment Analysis of the US Medical Device ... http://photos.prnewswire.com/prnh/20130307/600769 ... device sector identifies the key trends and rationale ... and mergers and acquisitions. The study ...
(Date:12/22/2014)... STOCKHOLM , Dec. 22, 2014 ... Pharmaceuticals, Inc. today announced that the Committee for Medicinal ... Agency (EMA) has adopted a positive opinion for the ... of adult men with Peyronie,s disease with a palpable ... at the start of therapy. The use ...
(Date:12/22/2014)... 2014  Eiger BioPharmaceuticals Incorporated announced the positive ... in patients with chronic hepatitis delta virus (HDV) ... Institutes of Health (NIH) Clinical Center in ... placebo-controlled, dose ascending study evaluated two doses of ... twice daily for 28 days.  "This proof-of-concept study ...
Breaking Medicine Technology:Investment Analysis of the US Medical Device Sector 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 3Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 4Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 5Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 6Eiger Bio Announces Positive Data in Patients Infected with Hepatitis Delta Virus (HDV) Treated with Lonafarnib - Results Presented at American Association for the Study of Liver Diseases (AASLD) Meeting 2Eiger Bio Announces Positive Data in Patients Infected with Hepatitis Delta Virus (HDV) Treated with Lonafarnib - Results Presented at American Association for the Study of Liver Diseases (AASLD) Meeting 3
... team of,researchers at West Virginia University has shown ... the habits of their adopted country, increasing,their risks ... cancer,among females., "Breast cancer and prostate cancer ... lifestyle play a major role in these cancers,",said ...
... Limited (ASX:,CYT) today announced that it is commencing ... company,s novel vascular-disrupting anticancer agent,in patients with an ... (GBM)., The GBM clinical trial is the ... tumor indications for the company and the second ...
Cached Medicine Technology:Immigrants From India, Pakistan Face U.S. Prostate, Breast Cancer Risks 2Cytopia Commences Second Phase II Study in Brain Cancer 2Cytopia Commences Second Phase II Study in Brain Cancer 3
(Date:12/24/2014)... December 24, 2014 New studies reveal that ... hearing loss related depression (March 6, 2014, JAMA Otolaryngology*). And ... hearing loss (about 50 percent according to recent polls) facing ... on how a person feels and relates to the world. ... improvements are also made by way of:, , ...
(Date:12/24/2014)... York, New York (PRWEB) December 24, 2014 ... ( http://www.xareltolawsuit2015.com/ ) that allege the blood thinner ... complications has outlined a leadership structure for the ... Order dated December 17th, the Court plans to ... the parties and also plans on appointing a ...
(Date:12/24/2014)... December 25, 2014 Today, Yunx.co.uk, a ... evening dresses and other special occasion outfits, unveils ... models are offered at discounted prices, up to 80% ... young ladies with their fashionable designs, gorgeous looks and ... exception. The business is devoted to designing and offering ...
(Date:12/24/2014)... 2014 Mike Billings , PT, ... Derek Fenwick, PT, MBA, GCS, Director of Professional ... from the passing of the Improving Medicare Post-Acute ... this taping of the Infinicast, the two leaders discuss ... Social Security Act to standardize post-acute assessment data for ...
(Date:12/24/2014)... Dennis Thompson HealthDay Reporter ... bisexual men who have abstained from sex for one year will ... new federal policy that would reverse a 31-year ban on donations ... and Drug Administration announced Tuesday its intention to release a new ... to blood donations from gay men. The FDA is changing ...
Breaking Medicine News(10 mins):Health News:Recent Studys Underscore the Fact That One of the Best Gifts to Give This Holiday Season is a Hearing Test 2Health News:Recent Studys Underscore the Fact That One of the Best Gifts to Give This Holiday Season is a Hearing Test 3Health News:Recent Studys Underscore the Fact That One of the Best Gifts to Give This Holiday Season is a Hearing Test 4Health News:Recent Studys Underscore the Fact That One of the Best Gifts to Give This Holiday Season is a Hearing Test 5Health News:Recent Studys Underscore the Fact That One of the Best Gifts to Give This Holiday Season is a Hearing Test 6Health News:Court Overseeing Federal Xarelto Lawsuits Issues Coordination Order, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal Xarelto Lawsuits Issues Coordination Order, Bernstein Liebhard LLP Reports 3Health News:Yunx.co.uk Unveils 65 New Bridesmaid Dresses for the UK market 2Health News:Latest Episode of Infinicast Features Infinity Rehab President Discussing IMPACT Act of 2014 and Changes for Post-Acute Therapy Providers in 2015 2Health News:FDA to Lift Ban on Blood Donations by Gay Men 2Health News:FDA to Lift Ban on Blood Donations by Gay Men 3
... 20 The following is a statement of ... http://www.newscom.com/cgi-bin/prnh/20080918/CFTFKLOGO ) The ... Harkin (D-IA) for his leadership role in Senate ... Food and Drug Administration (FDA) regulatory authority over ...
... Balance, Inc. (Nasdaq: SMBL ) today held its ... CEO Stephen Hughes spoke to stockholders about the Company,s progress ... year, consumers have found Smart Balance,s brand proposition compelling as ... of spreads," Hughes said. "We are excited as ever ...
... Minnesota MINNEAPOLIS, May 20 Today ClearWay Minnesota,s ... to reducing tobacco,s harm through coalition building, public ... resources to communities outside the Twin Cities metro ... to reducing tobacco,s harm and educate all Minnesotans ...
... the Archdiocese of Boston may soon refer women ... Centene Corp. and archdiocese-run Caritas Christi Health Care.(Logo: ... over the impact of nationalized health care on ... to ethically compromise with a potential federal health ...
... in only one-third of cases, study says , , WEDNESDAY, May ... come to a hospital with the intense chest pain that ... procedures within a few hours, a new Canadian study finds. ... attack and won,t be harmed by waiting a day or ...
... highlighted in June 2009 issue of Pregnancy BALTIMORE, May ... "Website We Can,t Live Without" for June 2009.The website ... rest and preterm labor that is current, concise, and ... and reliable, and then gives women a place to ...
Cached Medicine News:Health News:Sen. Tom Harkin Votes to Protect America's Kids From Tobacco 2Health News:Sen. Tom Harkin Votes to Protect America's Kids From Tobacco 3Health News:ClearWay Minnesota(SM) Board Approves Four Regional Grants 2Health News:ALL: Boston Archdiocese Reportedly on Track for Abortion Referring Venture 2Health News:When Chest Pain Requires Quick Action in ER 2Health News:When Chest Pain Requires Quick Action in ER 3Health News:Pregnancy Magazine Names KeepEmCookin.com its 'Website We Can't Live Without' 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: